Localized MAGnetIC hyperthermia CELL-based GENE therapy for immune modulation - MagicCELLGene

Project summary

The goal of MagicCELLGene is to develop a novel, universal and highly efficient methodology for transfection triggered by magnetic hyperthermia, with potential clinical applications in cell-based gene therapy. Our innovative approach is to induce a controlled and localized heating of the cellular membrane (hotspots) using magnetic nanoparticles covalently immobilized onto cell membranes via bioorthogonal chemistry; the reversible changes of the cell membrane permeability/fluidity will be used to promote the artificial delivery of nucleic acids into cells. Efforts will be especially focused on hard-to-transfect cells (primary cells), thus clearly addressing an unmet need of the transfection market. Expected results going beyond the state-of-the-art in transfection are: i) the development of a universal transfection tool and ii) its application to systems where standard transfection methods have several bottlenecks using as a model immune system modulation.

Project Details

Call

Call 2016


Call Topic

Interfaces between materials and biological hosts for health applications


Project start

01.09.2017


Project end

28.02.2021


Total project costs

463.522 €


Total project funding

337.313 €


TRL

2 - 4


Coordinator

Dr. Valeria Grazú

Consejo Superior de Investigaciones Científicas - Instituto de Ciencia de Materiales de Aragón, Edificio I+D, c/ Mariano Esquillor s/n, 50018 Zaragoza, Spain


Partners and Funders Details

Consortium Partner   Country Funder
Consejo Superior de Investigaciones Científicas - Instituto de Ciencia de Materiales de Aragón
https://www.csic.es; www.icma.unizar-csic.es
Research org. Spain ES-MINECO
Universidad de Zaragoza
https://www.unizar.es
University Spain ES-MINECO
Associação para a Inovação e Desenvolvimento da FCT (NOVA.ID.FCT)
https://www.fct.unl.pt; http://sites.fct.unl.pt/nanotheranostics
University Portugal PT-FCT

Keywords

nanotechnology, magnetic materials, cell membrane, nanobiomedicine, biointerfaces